<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609451</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB-REF-NR-266/07_Ileostomy</org_study_id>
    <nct_id>NCT02609451</nct_id>
  </id_info>
  <brief_title>Closure of Protective Ileostomy 2 vs. 12 Weeks After TME</brief_title>
  <acronym>Closure2vs12</acronym>
  <official_title>Closure of Protective Ileostomy 2 vs. 12 Weeks Following Total Mesorectal Excision (TME) for Rectal Surgery: Interim Analysis of a Multicentre, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Liestal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Liestal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the feasibility, safety, and quality of life (QOL) in
      patients (pts) undergoing protective ileostomy closure after 2 weeks with a closure after 12
      weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In three surgical departments between 2007 and 2013, 72 pts with total mesorectal excision
      and coloanal or low colorectal anastomosis for rectal cancer were randomly assigned to
      closure of their protective ileostomy after 2 weeks (group A, 37 pts) or 12 weeks (group B,
      35 pts). One day before planned stoma closure, the coloanal/colorectal anastomosis was
      checked by palpation, contrast enema via ileostomy and, in case of hazards, by proctoscopy.
      Perioperative data was assessed prospectively using numeric values, visual analogue scales
      (VAS, 0 = lowest value, 100 = highest value) and QOL-index (GQLI, max. 144 points).
      Complications were recorded prospectively.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Evidence of bad outcome after interims analysis
  </why_stopped>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality Of Life (GQLI - Questionnaire)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Quality Of Life Survey using the GQLI - Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feasibility (via Visual Analogue Scale)</measure>
    <time_frame>intraoperatively</time_frame>
    <description>Surgical Feasibility including blood loss, blood oozing, epifascial and intrabdominal adhesions, operating time and difference in bowel diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety as assessed by Morbidity, Mortality</measure>
    <time_frame>6 weeks, 16 weeks</time_frame>
    <description>Morbidity, Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality Of Life (EORTC - Questionnaire)</measure>
    <time_frame>preoperative (preOP), 6 weeks, 16 weeks</time_frame>
    <description>Quality Of Life Survey using the EORTC - QLQ C30 - Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality Of Life (GQLI - Questionnaire)</measure>
    <time_frame>preOP, 16 weeks</time_frame>
    <description>Quality Of Life Survey using the GQLI - Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>2 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ileostomy closure after 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ileostomy closure after 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ileostomy closure</intervention_name>
    <description>Ileostomy closure at a different time point</description>
    <arm_group_label>2 weeks</arm_group_label>
    <arm_group_label>12 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  anastomosis ≤ 5cm from anal verge

          -  age &gt;18 years

          -  informed consent

          -  uneventful course after first operation

        Exclusion Criteria:

          -  pregnancy

          -  allergy to contrast agent

          -  severe non-surgical complications

          -  evident abdominal - pelvic complications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph A. Maurer, Prof.Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Baselland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonspital Baselland Liestal</name>
      <address>
        <city>Liestal</city>
        <state>Baselland</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Thalheimer A, Bueter M, Kortuem M, Thiede A, Meyer D. Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum. 2006 Jul;49(7):1011-7.</citation>
    <PMID>16598401</PMID>
  </reference>
  <reference>
    <citation>O'Leary DP, Fide CJ, Foy C, Lucarotti ME. Quality of life after low anterior resection with total mesorectal excision and temporary loop ileostomy for rectal carcinoma. Br J Surg. 2001 Sep;88(9):1216-20.</citation>
    <PMID>11531870</PMID>
  </reference>
  <reference>
    <citation>Hallböök O, Matthiessen P, Leinsköld T, Nyström PO, Sjödahl R. Safety of the temporary loop ileostomy. Colorectal Dis. 2002 Sep;4(5):361-364.</citation>
    <PMID>12780582</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2015</study_first_submitted>
  <study_first_submitted_qc>November 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>quality of life</keyword>
  <keyword>feasibility</keyword>
  <keyword>safety</keyword>
  <keyword>protective ileostomy closure</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

